Product Information
TIZANIDINE HCL 2 MG CAPSULE is a generic product labeled by Nivagen Pharmaceuticals Inc., priced at $0.0830 per EA under NDC 75834020715. Its NADAC has been published 268 times since Jan 22, 2020.
FDA first approved this application on Mar 26, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the TIZANIDINE HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
2 mg/1
Manufacturer
Nivagen Pharmaceuticals Inc.NDC
75834020715
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Effective Date
2/19/2025
Active Ingredients
TIZANIDINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA210021FDA Approved
3/26/2019
TE Code
AB
On Market Since
9/26/2019
Pharmacological Classes
Price Statistics
The NADAC for TIZANIDINE HCL 2 MG CAPSULE has been published 268 times since Jan 22, 2020, and over the history we have for it it has declined 83.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0830 per EA |
|---|---|
| All-time high | $0.4993 (Feb 12, 2020) |
| All-time low | $0.0693 (May 17, 2023) |
| Median price | $0.1064 |
| Average price | $0.1346 |
| Largest weekly change | +60.8% (Jul 22, 2020) |
| Weeks tracked | 268 |
| Tracking since | Jan 22, 2020 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
-3.7%
5Y
-26.0%
All
-83.4%
Last surveyed Mar 5, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the TIZANIDINE HYDROCHLORIDE market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Nivagen Pharmaceuticals Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
TIZANIDINE HYDROCHLORIDE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Central alpha-2 Adrenergic Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of TIZANIDINE HCL 2 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for TIZANIDINE HCL 2 MG CAPSULE, manufactured by Nivagen Pharmaceuticals Inc., is $0.0830 per EA (NDC 75834020715), effective Mar 5, 2025.
How has the price of TIZANIDINE HCL 2 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for TIZANIDINE HCL 2 MG CAPSULE has declined 83.4%. It has been tracked across 268 weekly CMS publications since Jan 22, 2020.
What are the highest and lowest recorded NADAC prices for TIZANIDINE HCL 2 MG CAPSULE?
Since Jan 22, 2020, the NADAC for TIZANIDINE HCL 2 MG CAPSULE has ranged from a low of $0.0693 (May 17, 2023) to a high of $0.4993 (Feb 12, 2020), with a median of $0.1064 per EA.
Are there cheaper alternatives to TIZANIDINE HCL 2 MG CAPSULE?
No other NADAC-published product currently shares the active ingredient and strength of TIZANIDINE HCL 2 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures TIZANIDINE HCL 2 MG CAPSULE?
TIZANIDINE HCL 2 MG CAPSULE (NDC 75834020715) is labeled by Nivagen Pharmaceuticals Inc., and CMS classifies it as a generic product.